| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer
6 companies
Jean Jacques Bienaime is Director at BMRN and has filed Form 4s across 6 companies. From September 2015 to August 2026, the filings on record show 21 open-market purchases and 123 sales. Jean Jacques Bienaime's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $31.2M at current prices.
Historically, Jean Jacques Bienaime's trades have earned a middling insider score of 68/100 across 67 rated trades. Over a 12-month horizon, 64.3% of those trades were profitable, with an average 12-month return of +8.5%.
The biggest single holding is BMRN (~$26.4M) as Director. The BMRN filings lean toward selling, a net 2,115,500 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 28, 2018 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 3,000 | $84.04 | $252,120.00 | -1.0% | |
| Dec 26, 2018 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 4,000 | $80.50 | $322,000.00 | -1.4% | |
| Dec 14, 2018 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 2,000 | $92.64 | $185,280.00 | -0.7% | |
| Dec 12, 2018 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 2,000 | $93.12 | $186,240.00 | -0.7% | |
| Nov 8, 2018 | INCY Incyte Corp | Director | Buy | 1,000 | $68.77 | $68,765.00 | +17.6% | |
| Nov 2, 2018 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 1,500 | $97.88 | $146,820.00 | -0.5% | |
| Nov 1, 2018 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 4,000 | $92.55 | $370,200.00 | -1.4% | |
| Oct 3, 2018 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 1,500 | $99.36 | $149,040.00 | -0.5% | |
| Sep 24, 2018 | IMUX Immunic, Inc. | Director | Sell | 26,619 | $0.30 | $8,001.67 | -59.0% | |
| Sep 13, 2018 | IMUX Immunic, Inc. | Director | Sell | 20,000 | $0.47 | $9,400.00 | -30.7% |